2-Bromo-5-fluorobenzaldehyde | CAS:94569-84-3

We serve 2-Bromo-5-fluorobenzaldehyde CAS:94569-84-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Bromo-5-fluorobenzaldehyde

Chemical Name:2-Bromo-5-fluorobenzaldehyde
CAS.NO:94569-84-3
Synonyms:5-FLUORO-2-BROMO BENZALDEHYDE; 
2-bromo-5-fluorophenyl carbaldehyde;
2-bromo-5-fluoro-benzaldehyde
Molecular Formula:C7H4BrFO
Molecular Weight:203.00800
 
Physical and Chemical Properties:
Density:1.67;
Melting point:51-56oC;
Boiling point:225.8oC;
Flash point:190oF;
Index of Refraction:1.584;
 
Specification:
Appearance:Off-white to light yellow crystal powder
Purity(GC):≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis



Contact us for information like 2-Bromo-5-fluorobenzaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-bromo-5-fluoro-benzaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-bromo-5-fluorophenyl carbaldehyde Use and application,2-bromo-5-fluoro-benzaldehyde technical grade,usp/ep/jp grade.


Related News: Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors.1-pyrazin-2-ylethanone manufacturer The Transport Security Administration (TSA) will issue a new security directive to airlines from Sunday, according to a person briefed on the restrictions.(2-Chloro-5-iodophenyl)[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methanone supplier The Transport Security Administration (TSA) will issue a new security directive to airlines from Sunday, according to a person briefed on the restrictions.3-(Diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one vendor In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.